SCHEMBL8330285

SCHEMBL8330285

COc1cccc(C2CC2N(C)C(=O)C2CC2)c1

nearest known ligand 0.57

Predicted protein targets (top 16)

geneUniProtsupporting neighboursconfidence
HSD17B1 P14061 1/20 0.48
HSD17B2 P37059 1/20 0.48
SLC9A1 P19634 1/20 0.48
MGLL Q99685 1/20 0.46
HTR2C P28335 4/20 0.46
HTR2A P28223 2/20 0.46
HTR2B P41595 2/20 0.46
MTNR1A P48039 3/20 0.43
MTNR1B P49286 3/20 0.43
RIPK1 Q13546 1/20 0.42
CHRM2 P08172 1/20 0.42
CHRM1 P11229 1/20 0.42
CHRM3 P20309 1/20 0.42
OPRK1 P41145 1/20 0.41
GPR88 Q9GZN0 1/20 0.41
FFAR1 O14842 2/20 0.41

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL8332789 0.85 SLC9A1 (0.51) SLC9A1MGLLHTR2CHTR2AHTR2B
SCHEMBL8330683 0.85 HTR2A (0.49) SLC9A1HTR2CHTR2AHTR2BCHRM2
SCHEMBL8332239 0.82 SLC9A1 (0.48) SLC9A1MGLLHTR2CHTR2AHTR2B
SCHEMBL8334785 0.82 SLC9A1 (0.48) SLC9A1MGLLHTR2CHTR2AHTR2B
SCHEMBL8329086 0.82 SLC9A1 (0.44) HSD17B1HSD17B2SLC9A1HTR2CHTR2A
SCHEMBL8332123 0.81 HTR2A (0.48) SLC9A1MGLLHTR2CHTR2AHTR2B
SCHEMBL8332882 0.80 HTR2A (0.47) SLC9A1HTR2CHTR2AHTR2BMTNR1A
SCHEMBL8329351 0.80 HTR2A (0.47) SLC9A1HTR2CHTR2AHTR2BMTNR1A
SCHEMBL8332736 0.80 HTR2C (0.49) SLC9A1HTR2CHTR2AHTR2BCHRM2
SCHEMBL6320354 0.74 SLC9A1 (0.60) SLC9A1HTR2CHTR2AHTR2BCHRM2

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-5889031-A CONTROLLING CIRCADIAN RHYTHMS BRISTOL-MYERS SQUIBB COMPNAY (US) 1999-03-30 US disclosed
US-5753709-A N-acyl-2 aryl cyclopropylmethylamine derivatives as melatonergics BRISTOL-MYERS SQUIBB COMPANY (US) 1998-05-19 US disclosed